Correvio Pharma Corp. Revenue
Correvio Pharma Corp. reported Revenue of $32.63 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2020-04-30
| Period end | Revenues 12 month |
|---|---|
| 2019-12-31 | $32.63M 20-F · filed 2020-04-30 |
| 2018-12-31 | $28.67M 20-F · filed 2020-04-30 |
| 2017-12-31 | $24.01M 20-F · filed 2020-04-30 |
| 2016-12-31 | $25.26M 20-F · filed 2018-04-30 |
| 2015-12-31 | $20.91M 20-F · filed 2018-04-30 |
| 2014-12-31 | $30.04M 40-F · filed 2016-03-29 |
| 2013-12-31 | $4.51M 40-F · filed 2015-03-27 |
| 2012-12-31 | $789.00K 40-F/A · filed 2014-04-30 |
| 2011-12-31 | $1.50M 20-F/A · filed 2013-04-18 |
| 2010-12-31 | $66.06M 20-F/A · filed 2013-04-18 |